Companies / South Africa

Local Success But Tiger Brands Has Eyes On The Future

May 2007 | Five Year Forecasts

Adcock Ingram is South Africa's second-largest drug

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Aspen's Attractiveness To Investors Increases

Industry / South Africa BMI View: The investor preference for developed market equities over emerging market equities has negatively impacted Aspen Pharmaceuticals's share price. Although the price may have been overinflated...

March 2011

Drug Prices Frozen For 2011, Japan Crisis May Undermine Agreement

Industry / South Africa BMI View: The strong performance of the South African rand (ZAR) may have been bad for the country's export-driven industries, but it has helped many domestic drugmakers. As a result, these companies were...

March 2011

Aspen And Eli Lilly Sign US$1mn License Agreement

Industry / South Africa South African generic drugmaker Aspen Pharmacare has signed an agreement worth US$1mn with Eli Lilly to manufacture tuberculosis (TB) medicines, including one type specifically for patients with multi-drug...

February 2010

Vaccine Manufacturer Gives Positive Outlook For Production

Industry / South Africa South African vaccine manufacturer Biovac Institute has announced that it is increasing production capacity to 35mn doses by 2013. The drugmaker's main market will be the rest of Africa, promoting continental...

January 2010

Southern African States Join To Encourage Local Pharmaceutical Industry

Industry / South Africa A new Southern African Generics Medicines Association (SAGMA) has been established to drive growth in the pharmaceutical sectors in the region. SAGMA plans to develop initiatives to encourage further...

December 2009